Research map: From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease

Back to the article

Papers in this map

  1. CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up · Fabian Müller · 2024 · 1085 citations · Cited by this paper
  2. Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT · Ryszard Swoboda · 2026 · 1 citation · Related
  3. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis · Jacob M. van Laar · 2014 · 764 citations · Cited by this paper
  4. Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols · 2026 · Related
  5. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma · Keith M. Sullivan · 2018 · 607 citations · Cited by this paper
  6. Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities · 2026 · Related
  7. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial · Richard K. Burt · 2011 · 578 citations · Cited by this paper
  8. Institutional risk management for out-of-specification commercial CAR-T products · 2026 · Related
  9. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases · Dominique Farge · 2009 · 363 citations · Cited by this paper
  10. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P973–P983) · 2026 · Related
  11. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial · Harold L. Atkins · 2016 · 328 citations · Cited by this paper
  12. Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice · 2026 · Related
  13. Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis · Richard K. Burt · 2019 · 315 citations · Cited by this paper
  14. CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy · 2026 · Related
  15. Autologous hematopoietic stem cell transplantation in multiple sclerosis · Giovanni L. Mancardi · 2015 · 250 citations · Cited by this paper
  16. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards · 2026 · Related
  17. Blood and marrow stem cell transsplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) · Alan Tyndall · 1997 · 246 citations · Cited by this paper
  18. Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis · 2026 · Related
  19. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party · Jörg Henes · 2020 · 123 citations · Cited by this paper
  20. EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT · 2026 · Related
  21. Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis · Giacomo Boffa · 2021 · 85 citations · Cited by this paper
  22. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. · Alan Tyndall · 1996 · 59 citations · Cited by this paper
  23. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis · Tomáš Kalinčík · 2023 · 59 citations · Cited by this paper
  24. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial · Gavin Brittain · 2024 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)